ANADYS PHARMACEUTICALS INC
Healthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer changeNov 30, 2011
- Results of operationsNov 7, 2011
- Entered a material agreement · Other material eventOct 19, 2011
- Delisting / listing-standard noticeSep 20, 2011
- Director / officer changeAug 26, 2011
- Director / officer changeAug 24, 2011
- Results of operationsAug 8, 2011
- Other material eventJul 7, 2011
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/ASCHEDULE 13G HOLDINGS REPORT AMENDMENTFeb 14, 2012
- SC 13G/AANADYS PHARMACEUTICALS, INC.Feb 14, 2012
- EFFECTDec 6, 2011
- EFFECTDec 6, 2011
- EFFECTDec 6, 2011
- EFFECTDec 6, 2011
- 15-12GFORM 15Dec 6, 2011
- S-8 POSPOST-EFFECTIVE AMENDMENT TO FORM S-8Dec 5, 2011
- S-8 POSPOST-EFFECTIVE AMENDMENT TO FORM S-8Dec 5, 2011
- S-8 POSPOST-EFFECTIVE AMENDMENT TO FORM S-8Dec 5, 2011
- S-8 POSPOST-EFFECTIVE AMENDMENT TO FORM S-8Dec 5, 2011
- S-8 POSPOST-EFFECTIVE AMENDMENT TO FORM S-8Dec 5, 2011
- S-8 POSPOST-EFFECTIVE AMENDMENT TO FORM S-8Dec 5, 2011
- S-8 POSPOST-EFFECTIVE AMENDMENT TO FORM S-8Dec 5, 2011
- S-8 POSPOST EFFECTIVE AMENDMENT TO FORM S-8Dec 5, 2011
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.